FFA
NEUE

Farther Finance Advisors’s NeueHealth NEUE Stock Holding History

Farther Finance Advisors’s Portfolio NEUE Stock Details NEUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-120
Closed -$632 – 4137
2024
Q2 		$632 Buy
120
+7
+6% +$42 ﹤0.01% 3217
2024
Q1 		$712 Buy
+113
New +$1.01K ﹤0.01% 2904

Other funds holding NEUE

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
DMC
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
RM
Redpoint Management Woodside, California $204M AUM 31.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
Greycroft New York $44.1M AUM 24.2% 1-Year Est. Return
PGH
Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Farther Finance Advisors's NEUE Position: Q3 2024 in Review

Farther Finance Advisors sold out of NeueHealth (NEUE) in Q3 2024, closing a stake of 120 shares — an estimated $632 sold.

Farther Finance Advisors first reported a position in NEUE in Q1 2024 and held it in 2 quarters. The position peaked at $712 in Q1 2024. 36 funds tracked by Wall St. Rank hold NEUE as of Q3 2024.

  • Farther Finance Advisors reported no remaining NeueHealth position as of Q3 2024 after selling out during the quarter.
  • Farther Finance Advisors sold 120 NeueHealth shares in Q3 2024, an estimated $632.
  • Farther Finance Advisors first reported a position in NeueHealth in Q1 2024 and held it in 2 quarters.
  • Farther Finance Advisors's NeueHealth position peaked at $712 in Q1 2024.
  • 36 funds tracked by Wall St. Rank held NeueHealth as of Q3 2024.

Based on Farther Finance Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.